Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04639895
Other study ID # 1/20
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 22, 2018
Est. completion date August 30, 2021

Study information

Verified date May 2022
Source Universidade da Madeira
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cognitive dysfunction is one of the different consequences of excessive alcohol consumption, affecting many domains associated with prefrontal and temporal lobes, such as attention, verbal fluency, and memory. This study will explore the clinical impact of two cognitive rehabilitation tools to promote cognitive improvements of AUD individuals.


Description:

Excessive consumption of alcohol affects many functions associated with the prefrontal and temporal lobes, including different executive functions, memory, and complex motor control. Among several treatments, the Transtheoretical Model, a multidisciplinary approach, is one of the most standardized. However, it lacks effective and innovative cognitive rehabilitation tools. In this study, two cognitive rehabilitation tools, already clinically validated for stroke patients, will be implemented to promote cognitive recovery of Alcohol Use Disorder (AUD) individuals under treatment in the Alcoholic Rehabilitation Center S. Ricardo Pampuri from Casa de Saúde S. João de Deus (Madeira, Portugal). Within a randomized controlled trial with 60 participants, this study intend to assess and compare the clinical effectiveness of both a paper-and-pencil tasks training and content equivalent virtual reality (VR) simulation of activities of daily living with time-matched standard treatment.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date August 30, 2021
Est. primary completion date August 30, 2020
Accepts healthy volunteers No
Gender All
Age group 35 Years to 65 Years
Eligibility Inclusion Criteria: - Inpatients of Centro de Alcoologia Ricardo Pampuri (with Alcohol use Disorder diagnosis) - Education (able to read and write) - Standard neuropharmacological protocol Exclusion Criteria: - Abuse of other substances - Neurological and psychiatric pathology (present or past) - Severe depressive symptoms as assessed by the Beck Depression Inventory - Visual problems that can affect the performance of the tasks (hemianopsy, diplopia)

Study Design


Intervention

Procedure:
Virtual Reality
The Virtual Reality group will be involved in the Standard treatment protocol and will perform personalized activities of daily living in a virtual city environment (Reh@City).
Paper and Pencil
The paper and Pencil group will be involved in the Standard treatment protocol and will perform personalized cognitive paper-and-pencil tasks, using the Task Generator tool.
Control Group
The standard treatment protocol.

Locations

Country Name City State
Portugal Instituto São João de Deus- CSSJD Funchal Funchal

Sponsors (2)

Lead Sponsor Collaborator
Universidade da Madeira Instituto São João de Deus

Country where clinical trial is conducted

Portugal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Montreal Cognitive Assessment (Cognitive Screening). Change from baseline in the Montreal Cognitive Assessment Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up
Primary Frontal Assessment Battery (FAB- Executive functioning). Change from baseline in the Frontal Assessment Battery. Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up
Primary SF-36 Medical Outcomes Study 36 - Item Short - Form Health Survey Change from baseline in the SF-36 Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up
Secondary Toulouse-Pieron (Attention). Change from baseline in the Toulouse-Pieron Cancellation Test. Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up
Secondary Verbal Paired Associates (WMS-III) (Memory). Change from baseline in the Verbal Paired Associates (WMS-III) Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up
Secondary Rey Complex Figure (Visuospatial skills and visual memory). Change from baseline in the Rey Complex Figure. Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up
Secondary Symbol Search and Coding (WAIS III). Change from baseline in the Symbol Search and Coding (WAIS III) Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up]
Secondary Letter-number sequencing (WAIS-III)- Working Memory Change from baseline in the Letter-number sequencing (WAIS III) Baseline, Post-intervention (4 weeks), 6-month and 12-month follow-up]
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04927364 - Examining the Effectiveness of Deep TMS in Veterans With Alcohol Use Disorder N/A
Active, not recruiting NCT04618653 - Comprehensive Process Model of AA-related Behavior Change
Recruiting NCT05471154 - Non-invasive Brain Stimulation of the Prefrontal Cortex in Substance Use Disorders N/A
Completed NCT05021640 - Study of DCR-AUD in Healthy Volunteers Phase 1
Not yet recruiting NCT05064228 - Mobile Rewarding Activity Centered Treatment N/A
Completed NCT04958655 - Mental Imagery Intervention for Alcohol Craving N/A
Recruiting NCT05252221 - Alcohol Telemedicine Consultation in Primary Care (ATC) N/A
Completed NCT06108115 - Smartphone-Based Intervention for Sleep Disturbance in Individuals Recovering From Alcohol Use Disorder N/A
Completed NCT02911285 - NAC for Treating Comorbid PTSD and SUD Phase 2
Recruiting NCT04598399 - Comparison of the Effectiveness of Two Psycho-physical Interventions: Mindfulness Based Relapse Prevention (MBRP) and Unguided Meditative Relaxation in Patients With Alcohol Use Disorder N/A
Completed NCT04827056 - Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study Phase 1
Completed NCT04974645 - Pilot: Digital Therapeutic vs Education for the Management of Problematic Substance Use N/A
Recruiting NCT05992272 - Cue Effects in Human Addiction: Pavlovian to Instrumental Transfer
Completed NCT04229095 - Medication Development in Alcoholism: Suvorexant Versus Placebo Phase 2
Recruiting NCT05534568 - The Oklahoma Parent-Child Assistance Program N/A
Completed NCT04925570 - The Anchor Study: Digitally Delivered Intervention for Reducing Problematic Substance Use Phase 2
Active, not recruiting NCT05492942 - Records for Alcohol Care Enhancement N/A
Recruiting NCT05015881 - Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder Phase 2/Phase 3
Active, not recruiting NCT05120856 - AAT-App Outpatient Trial N/A
Not yet recruiting NCT06136195 - Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers Phase 2